South Korea Deputy Prime Minister Warns AI Wealth Gap Risks Worsening Amid Samsung Labor Disputes Nvidias Earnings Highlight 200 Billion Edge Computing Opportunity and China Market Retreat Surge in LongDated Treasury Yields Prompts Bond Investors to Rethink RiskFree Assumptions Fed Rate Cut Prospects Fade as Jobs Report Highlights Persistent Cost Pressures Ferrari Launches First AllElectric Model Luce Stirring Debate and Market Competition Inside the Secretive and HighMargin World of Orchid Breeding AIFF Q3 1998 Earnings EPS Plunges to 1290 Missing Estimates by 483 REPL Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins BUSEP Q1 2026 Earnings Preferred Stock Delivers Strong EPS Surprise UVV Q1 2026 Earnings EPS Miss Signals Challenging Start to Fiscal Year Evolution Global Acquisition Corp Units EVOXU Holds Steady at 1017 Amid Consolidation Aptorum Group Limited APM Hovers Near Support at 080 After Marginal Decline DEFSEC Technologies Slides as Resistance Holds Steady Key Levels Under Watch Envirotech Vehicles Inc EVTV Surges 1689 as Momentum Builds Above Key Support GEE Group Inc JOB Edges Higher as Stock Attempts to Stabilize Near Key Support Indias Tax Administration Overhaul Planned for Seamless GST Rollout GERN Q1 2026 Earnings NarrowerthanExpected Loss Fuels Investor Optimism Marcus Corporation MCS Holds Steady Amid Modest Pullback Key Levels in Focus INKT Q1 2026 Earnings BetterThanExpected Loss Drives 159 Stock Rally EMBJ Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick XYF Q1 2020 Earnings Severe EPS Miss Amid Challenging Environment BATRK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Improved Cost Management zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent ICE Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech